Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Shape Vantage vs Wisp

Shape Vantage
Graded #499

Lower grade

vs+32
Wisp
Graded #59

Higher grade

The verdict

Wisp takes it — 75/100 to 43/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +48
35
83
Dose & formulationWisp +36
52
88
Clinical oversightWisp +46
36
82
Labs & monitoringWisp +5
48
53
FulfillmentWisp +24
42
66
Contract termsEven
55
55
Shape Vantage · left barWisp · right bar

The numbers

MetricShape VantageWisp
WeighScore43/10075/100
GradeCC
Scorecard rank#499#59
SemaglutideNot disclosed$225/mo (compounded oral)
Tirzepatide$599/mo (compounded)$99/mo (starting dose, brand-name)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Shape Vantage

Graded #499 · C

Strengths

  • $599 product price shown publicly, not gated behind intake
  • Terms of Service exists and discloses the legal relationship
  • Positions itself as 'Premium Weight Loss Treatment'

Where it loses points

  • Homepage uses a dietary-supplement-style disclaimer, not language seen on legitimate prescription products
  • Links straight to a Stripe checkout with no medical intake, consultation, or prescription gate
  • Terms reserve the option to ship without prescription or provider review where not legally required
  • No LegitScript, NABP, state-pharmacy, or PCAB accreditation visible
  • Legal entity and state of incorporation not disclosed (only California governing law)
Wisp

Graded #59 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard